帳號:會員編號 密碼:預設為身分證字號 ( 第一個為英文大寫 )
|
|
Special Symposium
|
TUA State-of-the-art Lecture
|
TUA State-of-the-Art Lectures
|
World Urology Forum
|
World Urology Forum
|
ISTUA
|
ISTUA: Special lecture
|
Oncology
|
TUA Symposium F
|
Prostate cancer
|
TUA Symposium I
|
Renal cell carcinoma
|
TUA Symposium M
|
Urothelial cancer
|
Lunch Symposium 2
|
Meet the expert: The update on PC management
|
Lunch Symposium 3
|
Optimized treatment strategy of mCRPC by PARP inhibitors
|
Lunch Symposium 4
|
Radiomolecular precision oncology for the diagnosis and treatment of metastatic prostate cancer: An ongoing revolution
|
Lunch Symposium 5
|
Improving outcomes with enfortumab vedotin in patients with locally-advanced and metastatic urothelial cancer
|
Lunch Symposium 7
|
Maximizing treatment outcomes from choosing NHTs
|
Lunch Symposium 9
|
Adjuvant immunotherapy in urothelial carcinoma
|
Lunch Symposium 10
|
Meet the expert – What’s new in RF treatments of NMIBC
|
Lunch Symposium 11
|
Maximizing treatment outcomes from choosing NHTs
|
Lunch Symposium 12
|
How to maximize clinical benefits for CRPC patients?
|
Lunch Symposium 14
|
Advanced and metastatic non-clear cell RCC
|
Lunch Symposium 15
|
How to optimize ADT therapy in PC and BPH treatment: From evidence to practice
|
Lunch Symposium 16
|
Precision medicine for urologic cancer
|
Industrial Session 2
|
Immunotherapy treatment in renal cell carcinoma
|
Industrial Session 3
|
The rapidly evolving landscape of first-line therapy in locally advanced or metastatic urothelial cancer
|
Industrial Session 5
|
Advances in a/m UC treatment
|
Functional Urology
|
PPCS Symposium
|
PPCS Symposium
|
TUA Symposium D
|
NLUTD Forum
|
TUA Symposium Q
|
The relation between microbiota and lower urinary tract disease
|
Meet the Experts 2
|
Update in interstitial cystitis / bladder pain syndrome
|
Special Forum 6
|
Update for urinary incontinence
|
Lunch Symposium 1
|
The game-changing minimally invasive treatment: UroLift
|
Andrology
|
TUA Symposium E
|
Prostatic artery embolization (PAE)
|
TUA Symposium J
|
Emerging non-pharmacological treatment of BPH: Ablative techniques
|
TUA Symposium N
|
Emerging non-pharmacological treatment of BPH: Non-ablative techniques
|
Industrial Session 6
|
New clinical thinking of PRP in the treatment of ED/PD
|
Endourology
|
Meet the Experts 1
|
Robot-assisted laparoscopic
|
Industrial Session 7
|
達文西輔助手術實境分析
|
Lunch Symposium 6
|
New clinical thinking of PRP in the treatment of ED/PD
|
Lunch Symposium 13
|
Overcome learning curve of robotic surgery
|
Special Forum 10
|
2023 Taiwan surgical robots symposium
|
Urolithiasis
|
TUA Symposium R
|
結石專場
|
Meet the Experts 3
|
Retrograde intrarenal surgery
|
Lunch Symposium 8
|
RIRS手術安全性
|
Industrial Session 1
|
Latest generation of RIRS: Safety and success rate risen-mini RiRS: 極細7.5fr一次性軟鏡搭配10fr可彎曲負壓導管
|
Industrial Session 4
|
New technology and current innovation in RIRS / Case study
|
Infection and Inflammation
|
TUA Symposium O
|
Recurrent urinary tract infection: Look back and go forward
|
Pediatrics
|
TUA Symposium H
|
Evaluation and management of lower urinary tract dysfunction in children
|
Workshop 6
|
兒童尿動力學工作坊
|
Transplantation
|
TUA Symposium B
|
Transplant
|
Special Forum 3
|
腎-泌尿跨領域學門對談
|
Video
|
Video Session 1
|
Video Session 1
|
Video Session 2
|
Video Session 2
|
Video Award
|
Video Award
|
Others
|
TUA Symposium A
|
健康政策與管理/產官學研之實務應用
|
TUA Symposium C
|
大語言模型對醫學的影響
|
TUA Symposium G
|
健保審查開箱
|
TUA Symposium K
|
基層泌尿醫師 不可不知的"知識"
|
TUA Symposium L
|
醫學論文寫作
|
TUA Symposium S
|
Primary aldosteronism: From diagnosis to treatment
|
TUA Symposium P
|
搶救核刪-申復、爭審與共識
|
Workshop 4
|
您想擁有人生第一個專利嗎?
|
Special Forum 2
|
醫學人文思維融入醫療服務-性別與文化
|
Special Forum 4
|
談醫療與法律的距離
|
Special Forum 5
|
三十而立,你立了嗎? [談職涯規劃]
|
Special Forum 7
|
遠距醫療 / 數位健康大未來
|
Special Forum 8
|
高齡照護
|
Special Forum 9
|
智慧醫療新時代,人工智慧的醫療照護應用
|
Senior Resident Debate
|
Senior Resident Debate 1
|
Senior Resident Debate 1
|
Senior Resident Debate 2
|
Senior Resident Debate 2
|
Nursing Forum
|
Nursing Forum
|
Nursing Forum: 泌尿護理須知
|